Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News | GenomeWeb

Longhorn Vaccines and Diagnostics said this week that it has been granted emergency use authorization from the US Food and Drug Administration for its influenza A/H1N1-09 Prime rRT-PCR assay.

The test was approved for use in high-complexity laboratories under the Clinical Laboratory Improvement Amendments act.

The Longhorn influenza test is a real-time, reverse transcriptase PCR assay that requires no mixing prior to use, Longhorn said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.